Solta Medical to Report Fourth Quarter 2012 Results Release and
Host Conference Call on February 19, 2013
HAYWARD, Calif., Feb. 5, 2013 /PRNewswire/ -- Solta Medical, Inc.
(NASDAQ: SLTM), a global leader in the medical aesthetics market,
today announced that it will release its financial results for the
fourth quarter ended December 31,
2012, after market close on Tuesday,
February 19, 2013. The Company will also host a
conference call and webcast on Tuesday,
February 19, 2013, at 4:30 p.m.
Eastern Time (1:30 p.m.
Pacific) to discuss the financial results and current corporate
developments. The dial-in number for the conference call is
877-941-0844 for domestic participants and 480-629-9835 for
international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe, and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers products to address a
range of skin issues under the industry´s six premier brands:
Thermage®, Fraxel®, Liposonix®, Isolaz®, CLARO® and Clear +
Brilliant®. Thermage is an innovative, non-invasive
radiofrequency procedure for tightening and contouring skin.
As the leader in fractional laser technology, Fraxel delivers
minimally invasive clinical solutions to resurface aging and sun
damaged skin. The Liposonix system uses advanced high–intensity
focused ultrasound (HIFU) technology to permanently destroy
targeted fat just beneath the skin in the treatment areas of the
abdomen and flanks as a noninvasive, nonsurgical approach to
aesthetic waist circumference reduction. Isolaz was the first
laser or light based system indicated for the treatment of
inflammatory acne, comedonal acne, pustular acne, and
mild–to–moderate inflammatory acne. CLARO is a personal care
acne system that is the first FDA cleared over–the–counter IPL
device that uses a powerful combination of both heat and light to
clear skin quickly and naturally. Clear + Brilliant is a
unique, cost–effective treatment that utilizes safe, fractional
laser technology to correct and prevent early signs of aging and is
FDA cleared and CE marked. Since 2002, over one million
Thermage, Fraxel and Isolaz procedures have been performed in over
100 countries. For more information about Solta Medical, call
1-877-782-2286 or log on to www.Solta.com.
© 2012 Solta Medical, Inc. All rights reserved. Thermage,
Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta
Medical are trademarks or registered trademarks of Solta Medical,
Inc. or its subsidiaries.
SOURCE Solta Medical, Inc.